Literature DB >> 36264424

Decreased Th1 Cells and Increased Th2 Cells in Peripheral Blood Are Associated with Idiopathic Inflammatory Myopathies Patients with Interstitial Lung Disease.

Lu Cheng1,2,3, Yanhong Li1,2,3, Yubin Luo1,2,3, Yu Zhou4, Ji Wen1,2,3, Yinlan Wu1,2,3, Xiuping Liang1,2,3, Tong Wu1,2,3, Chunyu Tan5,6,7, Yi Liu8,9,10.   

Abstract

Interstitial lung disease (ILD) is a highly fatal manifestation of idiopathic inflammatory myopathies (IIMs). Th cells play important roles in the initiation of ILD. Here, we investigated the clinical significance of peripheral blood Th cells in IIMs-ILD patients. Eleven healthy controls (HC) and 53 patients diagnosed with IIMs were included, including 30 with ILD (IIMs-ILD) and 23 without ILD (IIMs-non-ILD). Circulating Th1, Th2, Th17, and Treg cells were examined by flow cytometry, and their correlation with clinical and laboratory findings was analyzed by Spearman's correlation and logistic regression. The proportion of Th1 cells decreased and Th2 cells increased in IIMs-ILD compared with IIMs-non-ILD (median (quartile): 2.99 (1.59-5.39) vs. 6.91 (3.48-10.04), p < 0.001; 2.67 (1.79-4.67) vs. 1.62 (0.85-2.66), p = 0.006) and correlated with disease activity. The Th1-cell proportion decreased in anti-MDA5 antibody-positive patients, while the Th2 cell proportion increased in patients with nonspecific interstitial pneumonia compared with IIMs-non-ILD (2.66 (1.06-4.35) vs. 6.91 (3.48-10.04), p = 0.002; 3.09 (2.03-5.72) vs. 1.62 (0.85-2.66), p = 0.016). Univariate analysis showed that a lower Th1 proportion, higher Th2 proportion increased, lower CK level, positivity for ARS, or anti-Ro52 antibodies (OR = 0.7122; OR = 1.679; OR = 0.9993; OR = 9.188; and OR = 6.161, respectively) were associated with the occurrence of ILD in IIMs patients. Decreased Th1 cells and elevated Th2 cells in peripheral blood may be involved in the pathogenesis of ILD in IIMs patients and have different effects on different serological and imaging subtypes.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Th1 cells; Th2 cells.; idiopathic inflammatory myopathies (IIMs); interstitial lung disease (ILD)

Year:  2022        PMID: 36264424     DOI: 10.1007/s10753-022-01747-5

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.657


  22 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis.

Authors:  Thomas Barba; Romain Fort; Vincent Cottin; Steeve Provencher; Isabelle Durieu; Sabine Jardel; Arnaud Hot; Quitterie Reynaud; Jean-Christophe Lega
Journal:  Autoimmun Rev       Date:  2018-12-17       Impact factor: 9.754

Review 3.  Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.

Authors:  Wanlong Wu; Li Guo; Yakai Fu; Kaiwen Wang; Danting Zhang; Wenwen Xu; Zhiwei Chen; Shuang Ye
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-06       Impact factor: 8.667

Review 4.  Interstitial lung disease in connective tissue disease--mechanisms and management.

Authors:  Athol U Wells; Christopher P Denton
Journal:  Nat Rev Rheumatol       Date:  2014-09-30       Impact factor: 20.543

Review 5.  Idiopathic inflammatory myopathies.

Authors:  Ingrid E Lundberg; Manabu Fujimoto; Jiri Vencovsky; Rohit Aggarwal; Marie Holmqvist; Lisa Christopher-Stine; Andrew L Mammen; Frederick W Miller
Journal:  Nat Rev Dis Primers       Date:  2021-12-02       Impact factor: 52.329

6.  Radiological versus histological diagnosis in UIP and NSIP: survival implications.

Authors:  K R Flaherty; E L Thwaite; E A Kazerooni; B H Gross; G B Toews; T V Colby; W D Travis; J A Mumford; S Murray; A Flint; J P Lynch; F J Martinez
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

7.  Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures.

Authors:  Leora J Vegosen; Clarice R Weinberg; Terrance P O'Hanlon; Ira N Targoff; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2007-08

Review 8.  The CD4-centered universe of human T cell subsets.

Authors:  J Geginat; M Paroni; F Facciotti; P Gruarin; I Kastirr; F Caprioli; M Pagani; S Abrignani
Journal:  Semin Immunol       Date:  2013-11-01       Impact factor: 11.130

Review 9.  The Stanford Health Assessment Questionnaire: dimensions and practical applications.

Authors:  Bonnie Bruce; James F Fries
Journal:  Health Qual Life Outcomes       Date:  2003-06-09       Impact factor: 3.186

Review 10.  T Cells in Fibrosis and Fibrotic Diseases.

Authors:  Mengjuan Zhang; Song Zhang
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.